Recent studies have shown that adipose-derived stem cells are able to inhibit mRNA expression levels of COL1A1, transforming growth factor β1, connective tissue growth factor and alpha actin 2 (ACTA2) in renal fibrosis tissues, thereby playing a therapeutic role in renal fibrosis [23]. This evidence concerns the gene COL1A1 and renal fibrosis.